TotalMarketCap

Ocular Therapeutix

OCULNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.413 B

$6.44 -9.87%

Close of 6 Nov 2026

As of 6 Nov 2026, Ocular Therapeutix (OCUL) has a market capitalization of $1.41B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$52.0M

#2702 by revenue

Earnings

-$265.9M

Loss-making

Shares outstanding

219,615,868

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #117Phibro Animal HealthPAHC$1.44B
  2. #118Tyra BiosciencesTYRA$1.43B
  3. #119Ocular TherapeutixOCUL$1.41B
  4. #120Ascentage Pharma Group InternationalAAPG$1.41B
  5. #121Rapport TherapeuticsRAPP$1.41B

What if Ocular Therapeutix were worth as much as…

Open the what-if tool →

Gold $28.2T

$128,573.92

Per share 19,980× higher

Bitcoin $1.53T

$6,956.91

Per share 1,081× higher

Apple $5.02T

$22,838.89

Per share 3,549× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Ocular Therapeutix are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.